Global Industry Analysts, Inc. (GIA) launches comprehensive analysis of industry segments, market trends, growth drivers, market share, size and demand forecasts on the global Vascular Closure Devices market. Market segmentation includes Type (Passive Approximators, Active Approximators, and External Hemostatic Devices).
Prior to vascular closure devices, manual and mechanical compression techniques were used for facilitating access site hemostasis. The techniques however, were ridden with many disadvantages including prolonged hospital stay for patients, increased discomfort, use of more hospital resources and ambulation time delays among others. VCDs, on the other hand, make possible quicker hemostasis leading to more accurate access site closures. Increasing CVDs prevalence leading to rise in cardiovascular procedure numbers, and growing number of new VCD approvals are the major factors supporting growth for the global VCD market since the past few years. CVDs have been one of the major causes behind deaths worldwide for quite some time now. By 2030, the number of deaths due to CVDs is anticipated to reach 24 million, as per the WHO. The significant rise in the number of cardiac interventional procedures therefore is anticipated to create strong demand growth scenario for VCDs over the coming years. Increasing use of imaging technologies for monitoring cardiac functions and radiotherapy has also been creating market growth opportunities as they lead to increase in heart surgeries demand.
Vascular Closure Devices are used for both interventional radiology or vascular surgeries and interventional cardiology with the latter accounting for the larger share in the market attributed to higher prevalence of CVDs and growing percentage of obese people in the world population. Interventional cardiology procedures offer benefits of less pain and reduced scarring because they are minimally invasive. This has been driving increased uptake of VCDs in this application. Interventional cardiologists deploy VCDs for closing arteries following the procedure. The procedures are catheter based treatments targeted at structural heart diseases mainly. They are carried out through blood vessels such as the transradial or transfemoral artery, for stenting and angioplasty.
This latest edition of the research study is conducted and published by Global Industry Analysts, Inc., in close collaboration with senior executives in the industry driving strategy, business development, marketing, sales, product management, technology and operations. The views, opinions and findings presented are based on validated engagements from a total executive pool size of 10443. Among this pool, 1253 direct interactions with domain experts were carried out via our proprietary market research platform, MarketGlass. Among the 313 unique participations, a total of 141 validated responses were received as part of this report's primary research outreach program. We are unique in the industry to provide our clients with the validated list executive engagements and the complete project data stack.
Key Competitors Covered in the Report -
Abbott Laboratories, Inc.
B. Braun Melsungen AG
Boston Scientific Corporation
Cardinal Health, Inc.
W. L. Gore & Associates, Inc.
Cordis, a Cardinal Health company
Merit Medical Systems, Inc.
Segments Covered in the Report -
Type (Passive Approximators, Active Approximators, External Hemostatic Devices)
Procedure (Interventional Cardiology, Interventional Radiology/Vascular Surgery)
Access (Femoral, Radial)
Geographies Analyzed in the Report -
Rest of Europe
Rest of Asia-Pacific
Rest of Latin America
Rest of Middle East
For enquiries e-mail us at sales@strategyR.com .
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (www.strategyr.com) is the world`s only influencer driven AI powered market research company. Serving more than 41,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for 33 years, offering the widest coverage of topics, geographic markets, competitive brands, and companies profiled.
Director, Corporate Communications
Global Industry Analysts, Inc.